
pmid: 24182860
Juvenile localized scleroderma (jLS) and juvenile systemic sclerosis (jSS) are both orphan diseases, with jLS around 10 times more frequent than jSS. In recent years the time gap between the appearance of symptoms and diagnosis has become significantly shorter. This review focuses on the new classifications of jSS and jLS, and on the developments and adaptations of the outcome measures for certain organ involvements whereby progress has been made regarding pediatric patients.
Scleroderma, Systemic, Ultrasonography, Doppler, Mycophenolic Acid, Antibodies, Monoclonal, Humanized, Microscopic Angioscopy, Uveitis, Scleroderma, Localized, Methotrexate, Thermography, Humans, Child, Glucocorticoids, Immunosuppressive Agents, Tomography, Optical Coherence, Skin
Scleroderma, Systemic, Ultrasonography, Doppler, Mycophenolic Acid, Antibodies, Monoclonal, Humanized, Microscopic Angioscopy, Uveitis, Scleroderma, Localized, Methotrexate, Thermography, Humans, Child, Glucocorticoids, Immunosuppressive Agents, Tomography, Optical Coherence, Skin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 22 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
